Article ; Online: Single-cell meta-analyses reveal responses of tumor-reactive CXCL13
Nature cancer
2022 Volume 3, Issue 9, Page(s) 1123–1136
Abstract: Immune-checkpoint blockade (ICB) therapies represent a paradigm shift in the treatment of human cancers; however, it remains incompletely understood how tumor-reactive T cells respond to ICB across tumor types. Here, we demonstrate that measuring CXCL13 ... ...
Abstract | Immune-checkpoint blockade (ICB) therapies represent a paradigm shift in the treatment of human cancers; however, it remains incompletely understood how tumor-reactive T cells respond to ICB across tumor types. Here, we demonstrate that measuring CXCL13 expression could effectively identify both precursor and terminally differentiated tumor-reactive CD8 |
---|---|
MeSH term(s) | CD8-Positive T-Lymphocytes/pathology ; Chemokine CXCL13 ; Humans ; Immune Checkpoint Inhibitors/pharmacology ; Immunotherapy ; Neoplasms/drug therapy ; Single-Cell Analysis ; Tumor Microenvironment |
Chemical Substances | CXCL13 protein, human ; Chemokine CXCL13 ; Immune Checkpoint Inhibitors |
Language | English |
Publishing date | 2022-09-22 |
Publishing country | England |
Document type | Journal Article ; Meta-Analysis ; Research Support, Non-U.S. Gov't |
ISSN | 2662-1347 |
ISSN (online) | 2662-1347 |
DOI | 10.1038/s43018-022-00433-7 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.